Agilent Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Agilent Technologies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Agilent Technologies in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
150.84153.15155.46
Details
Intrinsic
Valuation
LowReal ValueHigh
137.14173.81176.12
Details
10 Analysts
Consensus
LowTarget PriceHigh
144.00175.40195.00
Details
Earnings
Estimates (7)
LowProjected EPSHigh
4.804.824.84
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Agilent Technologies. Your research has to be compared to or analyzed against Agilent Technologies' peers to derive any actionable benefits. When done correctly, Agilent Technologies' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Agilent Technologies.

Agilent Technologies Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Agilent Technologies and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Agilent and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Agilent Technologies does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Agilent Technologies Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Agilent Stock performing well and Agilent Technologies company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Agilent Technologies' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
ACER 3.03  0.12  0.03  0.20  3.74  0.033 (3.27)  7.41 (6.61)  16.50 
ABUS 2.89  0.14  0.03  0.26  3.27  0.0348 (3.12)  5.68 (4.71)  15.91 
ACHV 2.99 (0.77)  0.00 (0.84)  0.00 (0.20)  0.00  5.29 (6.05)  18.68 
ABEO 5.21  0.35  0.04  2.55  6.13  0.0383 (5.75)  12.24 (8.98)  42.59 
ACIU 3.88 (0.21)  0.00 (0.11)  0.00 (0.037)  0.00  8.92 (7.34)  35.67 
ACB 4.76 (0.25)  0.00 (0.02)  0.00 (0.0217)  0.00  10.40 (7.41)  26.64 
ACRS 3.38  0.07  0.01  0.19  4.73  0.0124 (3.26)  6.21 (7.06)  21.28 
ACOR 9.59  1.84  0.21  0.63  8.00  0.09 (15.31)  13.33 (18.89)  189.94 
ACAD 2.50 (0.16)  0.00 (0.01)  0.00 (0.0329)  0.00  5.59 (5.64)  18.55 

Cross Equities Net Income Analysis

Select Fundamental

2010201120122013201420152016201720182019202020212022
ACER(5.5 M)(6 M)(8.9 M)(16.7 M)(15.1 M)(12 M)(8 M)(14.2 M)(21.3 M)(29.4 M)(22.9 M)(15.4 M)(16.6 M)
ABUS(10.1 M)(10.1 M)29.6 M(14.1 M)(38.8 M)(62.7 M)(384.2 M)(84.4 M)(57.1 M)(153.7 M)(63.7 M)(76.2 M)(82.3 M)
ACHV(12.6 M)(14.7 M)(21.1 M)(31.8 M)(26.2 M)(16.8 M)(20.1 M)(20.1 M)(20.1 M)(20.1 M)(20.1 M)(23.1 M)(25 M)
ABEO(7.5 M)(2.5 M)(10.5 M)4.4 M(26.8 M)(14.5 M)(21.9 M)(27.3 M)(56.7 M)(76.3 M)(84.2 M)(84.9 M)(87.2 M)
ACIU10.7 M10.7 M10.7 M10.7 M10.7 M20.3 M(7.1 M)(26.4 M)(51 M)45.4 M(61.9 M)(73 M)(74.9 M)
ACB(5.7 M)(5.7 M)(5.7 M)(5.7 M)(5.7 M)(5.7 M)(5.7 M)63.8 M(320.1 M)(3.4 B)(697.2 M)(627.5 M)(677 M)
ACRS(5.2 M)(5.2 M)(5.2 M)(5.2 M)(8.5 M)(20.6 M)(48.1 M)(68.5 M)(132.7 M)(161.4 M)(51 M)(90.9 M)(98 M)
ACOR(11.8 M)30.6 M155 M16.4 M17.7 M11.1 M(34.6 M)(223.4 M)33.7 M(273 M)(99.6 M)(104 M)(106.7 M)
ACAD15.1 M(22.8 M)(20.8 M)(37.9 M)(92.5 M)(164.4 M)(271.4 M)(289.4 M)(245.2 M)(235.3 M)(281.6 M)(167.9 M)(181.1 M)

Agilent Technologies and related stocks such as Acer Therapeutics, Arbutus Biopharma Corp, Achieve Life Sciences, Abeona Therapeutics, AC Immune, Aurora Cannabis, Aclaris Therapeutics, Acorda Therapeutics, and ACADIA Pharmaceuticals Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Agilent Technologies financial statement analysis. It represents the amount of money remaining after all of Agilent Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Agilent Technologies Competitive Analysis

The better you understand Agilent Technologies competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Agilent Technologies' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Agilent Technologies' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
AACERABUSACHVABEOACIUACBACRSACORACAD
 2.13 
 155.67 
Agilent
 3.85 
 1.50 
Acer Therapeutics
 1.20 
 2.48 
Arbutus
 1.43 
 2.75 
Achieve
 1.01 
 3.99 
Abeona
 4.47 
 2.57 
AC Immune
 4.11 
 1.40 
Aurora
 5.85 
 16.64 
Aclaris
 1.61 
 0.61 
Acorda
 2.54 
 15.76 
ACADIA
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Annual Yield
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Target Price
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Agilent Technologies Competition Performance Charts

Complement your Agilent Technologies position

In addition to having Agilent Technologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Diversified Assets Thematic Idea Now

Diversified Assets
Diversified Assets Theme
Pablicly traded close-end funds and other entities backed by different types of diversified investments. The Diversified Assets theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Diversified Assets Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Agilent Technologies Correlation with its peers. Note that the Agilent Technologies information on this page should be used as a complementary analysis to other Agilent Technologies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Agilent Stock analysis

When running Agilent Technologies price analysis, check to measure Agilent Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Agilent Technologies is operating at the current time. Most of Agilent Technologies' value examination focuses on studying past and present price action to predict the probability of Agilent Technologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Agilent Technologies' price. Additionally, you may evaluate how the addition of Agilent Technologies to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Is Agilent Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agilent Technologies. If investors know Agilent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agilent Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.15) 
Market Capitalization
45.9 B
Quarterly Revenue Growth YOY
0.11
Return On Assets
0.0953
Return On Equity
0.23
The market value of Agilent Technologies is measured differently than its book value, which is the value of Agilent that is recorded on the company's balance sheet. Investors also form their own opinion of Agilent Technologies' value that differs from its market value or its book value, called intrinsic value, which is Agilent Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agilent Technologies' market value can be influenced by many factors that don't directly affect Agilent Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Agilent Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Agilent Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agilent Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
A
 Stock
  

USD 155.67  3.24  2.13%   

Agilent Technologies competes with Acer Therapeutics, Arbutus Biopharma, Achieve Life, Abeona Therapeutics, and AC Immune; as well as few others. The company operates under Life Sciences Tools & Services sector and is part of Health Care industry. Analyzing Agilent Technologies competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Agilent Technologies to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Agilent Technologies competition on your existing holdings. Please continue to Agilent Technologies Correlation with its peers.
  
As of December 5, 2022, Return on Investment is expected to decline to 13.64. In addition to that, Return on Average Assets is expected to decline to 9.00. Agilent Technologies Current Assets are projected to decrease significantly based on the last few years of reporting. The past year's Current Assets were at 4.37 Billion. The current year Revenue to Assets is expected to grow to 0.70, whereas Total Assets are forecasted to decline to about 11.9 B.